Oric Pharmaceuticals, Inc. ORIC Return on equity

Return on equity at other companies

PfizerPFE

10.6%—

ArriVent BioPharma, Inc.AVBP

-55.2%+8.0pp

CG OncologyCGON

-26.4%+9.3pp

Olema Pharmaceuticals, Inc.OLMA

-42.9%+1.3pp

Stoke Therapeutics, Inc.STOK

-45.6%-66.1pp

Ionis PharmaceuticalsIONS

-105.5%+336pp

FAQ

What is Oric Pharmaceuticals, Inc.'s return on equity?

Oric Pharmaceuticals, Inc. (ORIC) reported return on equity of -42.6% in Q1 2026.

How has Oric Pharmaceuticals, Inc.'s return on equity changed year-over-year?

Oric Pharmaceuticals, Inc.'s return on equity increased by 12.1% year-over-year, from -48.5% to -42.6%.

What is the long-term trend for Oric Pharmaceuticals, Inc.'s return on equity?

Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s return on equity has grown at a 10.2% compound annual growth rate (CAGR), from -28% to -41.3%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.